Medartis Holding AG (XSWX:MED) 3-Month Share Buyback Ratio: 0.00% (As of Dec. 2025 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:MED Medartis Holding AG XSWX:MED
82 GF Score
Price CHF86.20
GF Value CHF107.79
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Medartis Holding AG 3-Month Share Buyback Ratio?

Medartis Holding AG XSWX:MED -0.23% 82 3-Month Share Buyback Ratio is 0.00 as of Dec. 2025. GuruFocus rates XSWX:MED with a GF Score™ of 82/100 and a GF Value™ of CHF107.79 (Modestly Undervalued). The stock has 4 warning signs investors should review.

3-Month Share Buyback Ratio only apply to companies whose reporting frequency is 3 months.

XSWX:MED
82GF Score
Medartis Holding AG XSWX:MED
3-Month Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a 3-Month Share Buyback Ratio of 0.00 mean?
Medartis Holding AG (XSWX:MED) has a 3-Month Share Buyback Ratio of 0.00 as of Dec. 2025. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Medartis Holding AG and its competitors.
Is Medartis Holding AG's 3-Month Share Buyback Ratio too high?
Medartis Holding AG's current 3-Month Share Buyback Ratio is 0.00. Overall, Medartis Holding AG has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medartis Holding AG's 3-Month Share Buyback Ratio compare to ABT and SYK?
Medartis Holding AG's 3-Month Share Buyback Ratio of 0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Month Share Buyback Ratio for a Medical Devices & Instruments company?
A good 3-Month Share Buyback Ratio depends on the Medical Devices & Instruments industry context. However, 3-Month Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Month Share Buyback Ratio mean?
A high 3-Month Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Medartis Holding AG and its competitors. Medartis Holding AG's current 3-Month Share Buyback Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medartis Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Medartis Holding AG (XSWX:MED) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF107.79, compared to a current price of CHF86.20 — trading 20% below its estimated fair value. The current 3-Month Share Buyback Ratio is 0.00. Medartis Holding AG's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Month Share Buyback Ratio calculated?
3-Month Share Buyback Ratio is calculated from a company's financial statements. For Medartis Holding AG (XSWX:MED), the current 3-Month Share Buyback Ratio is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medartis Holding AG (XSWX:MED) Overvalued in 2026?

Based on GuruFocus' analysis, Medartis Holding AG stock appears to be undervalued. The current stock price of CHF86.20 is trading 20% below its estimated GF Value™ of CHF107.79. GuruFocus considers Medartis Holding AG to be Modestly Undervalued.

Key valuation signals for XSWX:MED:

  • 3-Month Share Buyback Ratio: 0.00
  • GF Value™: CHF107.79 vs. price of CHF86.20 (20% below fair value)
  • GF Score™: 82/100 with 4 warning signs

No single metric tells the full story. See the XSWX:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medartis Holding AG Business Description

Other Exchanges MEDz:UK1RU:Germany
Address Hochbergerstrasse 60E, Basel, CHE, 4057
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from Europe, Middle East and Africa (EMEA) and also has a presence in North America, Asia Pacific, and Latin America.
82GF Score

Get the complete analysis for XSWX:MED

3-Month Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF86.20
Price
CHF107.79
GF Value